Segments of Business and Geographic Areas (Tables)

3 Months Ended

Mar. 30, 2014



	Fiscal First Quarters Ended
(Dollars in Millions)	March 30, 2014		March 31, 2013	Percent Change

Consumer
United States	$	1,309	1,348	(2.9	)%
International	2,248		2,327	(3.4	)
Total	3,557		3,675	(3.2	)
Pharmaceutical
United States	3,740		3,471	7.7
International	3,758		3,297	14.0
Total	7,498		6,768	10.8
Medical Devices & Diagnostics
United States	3,155		3,206	(1.6	)
International	3,905		3,856	1.3
Total	7,060		7,062	0.0
Worldwide
United States	8,204		8,025	2.2
International	9,911		9,480	4.5
Total	$	18,115	17,505	3.5	%

Operating profit by segment of business



	Fiscal First Quarters Ended
(Dollars in Millions)	March 30, 2014		March 31, 2013	Percent Change
Consumer ⁽¹⁾	$	479	547	(12.4	)%
Pharmaceutical ⁽²⁾	3,206		2,417	32.6
Medical Devices & Diagnostics⁽³⁾	1,966		1,518	29.5
Segments operating profit	5,651		4,482	26.1
Less: Expense not allocated to segments⁽⁴⁾	227		221
Worldwide income before taxes	$	5,424	4,261	27.3	%

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas



	Fiscal First Quarters Ended
(Dollars in Millions)	March 30, 2014		March 31, 2013	Percent Change
United States	$	8,204	8,025	2.2	%
Europe	4,885		4,481	9.0
Western Hemisphere, excluding U.S.	1,695		1,783	(4.9	)
Asia-Pacific, Africa	3,331		3,216	3.6
Total	$	18,115	17,505	3.5	%

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details